eady flow of elite scientists at all times up to and through the closi...Additionally the Cellceutix team was proud that once again during thi...About Cellceutix ...Cellceutix Corporation is a preclinical cancer anti-inflammatory and ...Kevetrin KM-133 and KM-391 have not been studied in humans at this t...

eady flow of elite scientists at all times up to and through the closing of the session." Dr. Holden continued, "The manner in which people gravitated to Cellceutix to learn about Kevetrin and its p53 breakthroughs attests to the value of Kevetrin as a novel cancer therapy. We were approached for in-depth conversations by representatives of the world's largest pharmaceutical companies and most prestigious universities in the United States. Moreover, we held a meeting with the National Cancer Institute to discuss the future for Kevetrin development as well. Now that people have gotten a first-hand look at our research explaining the mechanism of action for Kevetrin, the interest that was starting to brew is truly intensifying as organizations of all sizes want to continue discussions back at our offices and lab."

Additionally, the Cellceutix team was proud that once again during this year's convention, Cellceutix Scientific Advisor, Dr. Emil Frei III, was honored by the AACR. Dr. Frei was a previous recipient of accolades from the AACR as the inaugural AACR Award for Lifetime Achievement in Cancer Research was given to him in 2004. In 2009, the AACR recognized Cellceutix cancer drug Kevetrin, as an elite drug in development due to promising potency during its first "Frontiers in Basic Cancer Research Meeting."

About Cellceutix

Cellceutix Corporation is a preclinical cancer, anti-inflammatory and autism drug developer. Cellceutix owns the rights to eight drug compounds, including Kevetrin, which it is developing as a treatment for certain cancers, KM-133, for the treatment of psoriasis, and KM-391, for the treatment of autism. More information is available on the Cellceutix web site at http://www.cellceutix.com.

Kevetrin, KM-133, and KM-391 have not been studied in humans at this time. The Company's positive results in animal studies do not necessarily guarantee su'/>"/>

(Date:7/30/2015)... WOODCLIFF LAKE, N.J. , July 30, 2015 /PRNewswire/ ... submitted simultaneously in the United States ... (to the FDA, EMA and MHLW, respectively) for eribulin, ... sarcoma (STS) who have received prior chemotherapy for advanced ... are based on data from a pivotal global Phase ...

(Date:7/31/2015)... ... July 31, 2015 , ... There’s no better way to enjoy the summer ... to cook the next meal, making July the most appropriate to be National Hot ... and recipes. , Make the next cookout different than the ones in the past. ...

(Date:7/31/2015)... ... July 31, 2015 , ... According to the article published July 27 on ... courthouse was contained and extinguished by the city’s fire department before it caused major damage ... the time of the fire, and it was a fire alarm system that tipped off ...

(Date:7/31/2015)... ... July 31, 2015 , ... Well-known for its unique ... wedding cakes with custom designs, making life just a little bit sweeter ... wedding cakes for each customer who orders one. , The bakery provides a full ...

... says that a serving or two of dark or bitter ... comes as a breath of fresh “sweet” air from Swiss ... at Zurich's University hospital. They investigated and found after tests ... cocoa content (75 per cent) improved their blood circulation "significantly". ...

... Executive Director Peter Ellis has revealed that a version of the ... dysfunction market is much larger when compared to that of men, ... pill for that, according to Ellis. The desire, arousal and pain ... the pill, which will make it all the more difficult to ...

... flight attendants working for a National European Airline from ... they rate their health as poor when they have ... to the other women who are working with the ... attention, being proposed, ogled at, subjected to offensive remarks ...

... brandy per day reportedly has a similar antioxidant potential which ... belonging to the Monash University. This does not mean that ... can continue along with drinking brandy. ,Red ... arteries are de-sludged by its consumption in addition to it ...

... at risk for high blood pressure, heart disease and ... current issue of the American Journal of Preventive Medicine. ... blood pressure, or hypertension, generally consume less sodium than ... than recommended levels, according to lead researcher Umed Ajani, ...

... The National Institutes of Health (NIH) has revealed that the ... the youngsters in the US. There has however been an ... purposes. The University of Michigan conducted the 2005 Monitoring the ... overall results were good. , ,It found that cigarette ...